Integrative biological studies of antitumour agents

Integrative biological studies of antitumour agents

Detalhes bibliográficos
Principais autores:	Johnson, L, Willis, A, Byrne, H, Laughton, C
Formato:	Conference item
Publicado em:	2008

Registros relacionados

An integrative biological approach to the analysis of tissue culture data: application to the antitumour agent RHPS4.
por: Johnson, L, et al.
Publicado em: (2011)

A systems biology approach to the analysis of DNA-interactive antitumour agents
por: Laughton, C, et al.
Publicado em: (2006)

The Chemistry of antitumour agents /
por: Wilman, Derry E. V.
Publicado em: (1990)

Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study
por: Magda A.-A. El-Sayed, et al.
Publicado em: (2018-01-01)

An approach to the generation of simple analogues of the antitumour agent spicamycin.
por: Mons, S, et al.
Publicado em: (2003)

Synthesis of quinazolindionyl amino acid and dipeptide derivatives as possible antitumour agents
por: A. Aboelmagd, et al.
Publicado em: (2019-07-01)

A highly cytotoxic L-rhamnose analogue of the antitumour agent spicamycin
por: Martin, A, et al.
Publicado em: (1998)

Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland
por: D Kyburz, et al.
Publicado em: (2020-02-01)

Synthesis and biological evaluation of enantiomeric rhamnose analogues of the antitumour agent spicamycin - is the mode of action by modification of N-linked glycoproteins?
por: Martin, A, et al.
Publicado em: (1999)

Antitumour-promoting and antitumour activities of the crude extract from the leaves of Juniperus chinensis
por: Ali, Abdul Manaf, et al.
Publicado em: (1996)

Biochemical mechanisms of platinum antitumour drugs /
por: McBrien, D. C. H., et al.
Publicado em: (1986)

On the antitumour effects of B vitamins
por: O. A. Gromova, et al.
Publicado em: (2024-02-01)

An Overview of Antitumour Activity of Polysaccharides
por: Hongzhen Jin, et al.
Publicado em: (2022-11-01)

TIN-BASED ANTITUMOUR DRUGS
por: Gielen, Marcel
Publicado em: (1994-05-01)

Novel disulfides with antitumour efficacy and specificity
por: Griffiths, R, et al.
Publicado em: (2005)

Antitumour principles from alpinia galanga /
por: Hideji Itokawa

Antitumour Effects of Astaxanthin and Adonixanthin on Glioblastoma
por: Shohei Tsuji, et al.
Publicado em: (2020-09-01)

R(h)oad to antitumour therapy
por: Viviane Nascimento Da Conceicao, et al.
Publicado em: (2022-12-01)

Adsorption of Some Antitumour Compounds on Polymer Adsorbents
por: M.O. Kovbuz, et al.
Publicado em: (1996-08-01)

Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin
por: Liu J, et al.
Publicado em: (2020-01-01)

Semisynthesis of Andrographolide Derivatives and Evaluation of Their Antitumour Properties
por: Rao, Jada Srinivasa
Publicado em: (2004)

The Antitumour Mechanisms of Carotenoids: A Comprehensive Review
por: Andrés Baeza-Morales, et al.
Publicado em: (2024-08-01)

Synthesis and antitumour activity of varitriol and its analogues
por: Oľga Caletková, et al.
Publicado em: (2012-05-01)

Recent Advances in Functional Carbon Quantum Dots for Antitumour
por: Cai R, et al.
Publicado em: (2021-10-01)

Functionalisation of Virus-Like Particles Enhances Antitumour Immune Responses
por: Katrin Kramer, et al.
Publicado em: (2019-01-01)

Antitumour Activity of Dehydroxymethylepoxyquinomycin (DHMEQ): a Literature Review
por: K. Umezawa, et al.
Publicado em: (2021-04-01)

A single‐domain small protein Med‐ORF10 regulates the production of antitumour agent medermycin in Streptomyces
por: Xiaofeng Cai, et al.
Publicado em: (2021-09-01)

Impact of oncogenic pathways on evasion of antitumour immune responses
por: Spranger, Stefani
Publicado em: (2020)

Synergistic Antitumour Properties of viscumTT in Alveolar Rhabdomyosarcoma
por: Rahel Mascha Stammer, et al.
Publicado em: (2017-01-01)

Bicarbonate transport as regulator of antitumour immunity in pancreatic cancer
por: Emily J. Kay, et al.
Publicado em: (2023-04-01)

Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics
por: Piao Zhou, et al.
Publicado em: (2021-01-01)

Increase of the antitumour efficacy of the biocompound IMMUNEPOTENT CRP by enzymatic treatment
por: Moises A. Franco-Molina, et al.
Publicado em: (2018-07-01)

Evaluation of the purified fraction of Wilbrandia (c. f. ) verticillata for antitumour activity
por: V. S. N. Rao, et al.
Publicado em: (1991-01-01)

Phenolic profile, antibacterial, antimutagenic and antitumour evaluation of Veronica urticifolia Jacq.
por: Jelena Živković, et al.
Publicado em: (2014-07-01)

Liposomal encapsulation enhances the antitumour efficacy of the vascular disrupting agent ZD6126 in murine B16.F10 melanoma.
por: Fens, M, et al.
Publicado em: (2008)

Boosting antitumour immunity through targeted delivery of interferon-α
por: Fairchild, P, et al.
Publicado em: (2019)

Advances in antitumour therapy with oncolytic herpes simplex virus combinations
por: Xuejiao Qi
Publicado em: (2024-07-01)

Learning the Lessons of Antitumour Necrosis Factor Therapy-Associated Psoriasis
por: Matt Shale, et al.
Publicado em: (2009-01-01)

Interactions between rnacrophage cytokines and eicosanoids in expression of antitumour activity
por: Shlomo Ben-Efraim
Publicado em: (1992-01-01)

Design, synthesis and antitumour activity evaluation of novel dolutegravir derivatives
por: Xi-Xi Hou, et al.
Publicado em: (2023-08-01)